Global Lung Cancer Genomic Testing Market Size, CAGR of 8%, Share, Report to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Lung Cancer Genomic Testing Market Size Analysis

Global Lung Cancer Genomic Testing Market Introduction
By Type
1. Introduction
  1. Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction (PCR)
  1. By Value
3. Next-Generation Sequencing (NGS)
  1. By Value
4. Fluorescence in Situ Hybridization
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Tissue biopsy
  1. By Value
3. Liquid biopsy
  1. By Value
By Panel Type
1. Introduction
  1. Panel Type By Value
2. Multi-Gene panels
  1. By Value
3. Single-Gene panels
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research organizations
  1. By Value
3. Hospitals/Clinics
  1. By Value
4. Diagnostic Laboratories
  1. By Value

North America Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction (PCR)
  1. By Value
3. Next-Generation Sequencing (NGS)
  1. By Value
4. Fluorescence in Situ Hybridization
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Tissue biopsy
  1. By Value
3. Liquid biopsy
  1. By Value
By Panel Type
1. Introduction
  1. Panel Type By Value
2. Multi-Gene panels
  1. By Value
3. Single-Gene panels
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research organizations
  1. By Value
3. Hospitals/Clinics
  1. By Value
4. Diagnostic Laboratories
  1. By Value
U.S.
1. By Type
  1. Introduction
    1. Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction (PCR)
    1. By Value
  3. Next-Generation Sequencing (NGS)
    1. By Value
  4. Fluorescence in Situ Hybridization
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Tissue biopsy
    1. By Value
  3. Liquid biopsy
    1. By Value
4. By Panel Type
  1. Introduction
    1. Panel Type By Value
  2. Multi-Gene panels
    1. By Value
  3. Single-Gene panels
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Research organizations
    1. By Value
  3. Hospitals/Clinics
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction (PCR)
  1. By Value
3. Next-Generation Sequencing (NGS)
  1. By Value
4. Fluorescence in Situ Hybridization
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Tissue biopsy
  1. By Value
3. Liquid biopsy
  1. By Value
By Panel Type
1. Introduction
  1. Panel Type By Value
2. Multi-Gene panels
  1. By Value
3. Single-Gene panels
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research organizations
  1. By Value
3. Hospitals/Clinics
  1. By Value
4. Diagnostic Laboratories
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction (PCR)
    1. By Value
  3. Next-Generation Sequencing (NGS)
    1. By Value
  4. Fluorescence in Situ Hybridization
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Tissue biopsy
    1. By Value
  3. Liquid biopsy
    1. By Value
4. By Panel Type
  1. Introduction
    1. Panel Type By Value
  2. Multi-Gene panels
    1. By Value
  3. Single-Gene panels
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Research organizations
    1. By Value
  3. Hospitals/Clinics
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction (PCR)
  1. By Value
3. Next-Generation Sequencing (NGS)
  1. By Value
4. Fluorescence in Situ Hybridization
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Tissue biopsy
  1. By Value
3. Liquid biopsy
  1. By Value
By Panel Type
1. Introduction
  1. Panel Type By Value
2. Multi-Gene panels
  1. By Value
3. Single-Gene panels
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research organizations
  1. By Value
3. Hospitals/Clinics
  1. By Value
4. Diagnostic Laboratories
  1. By Value
China
1. By Type
  1. Introduction
    1. Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction (PCR)
    1. By Value
  3. Next-Generation Sequencing (NGS)
    1. By Value
  4. Fluorescence in Situ Hybridization
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Tissue biopsy
    1. By Value
  3. Liquid biopsy
    1. By Value
4. By Panel Type
  1. Introduction
    1. Panel Type By Value
  2. Multi-Gene panels
    1. By Value
  3. Single-Gene panels
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Research organizations
    1. By Value
  3. Hospitals/Clinics
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction (PCR)
  1. By Value
3. Next-Generation Sequencing (NGS)
  1. By Value
4. Fluorescence in Situ Hybridization
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Tissue biopsy
  1. By Value
3. Liquid biopsy
  1. By Value
By Panel Type
1. Introduction
  1. Panel Type By Value
2. Multi-Gene panels
  1. By Value
3. Single-Gene panels
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research organizations
  1. By Value
3. Hospitals/Clinics
  1. By Value
4. Diagnostic Laboratories
  1. By Value
UAE
1. By Type
  1. Introduction
    1. Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction (PCR)
    1. By Value
  3. Next-Generation Sequencing (NGS)
    1. By Value
  4. Fluorescence in Situ Hybridization
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Tissue biopsy
    1. By Value
  3. Liquid biopsy
    1. By Value
4. By Panel Type
  1. Introduction
    1. Panel Type By Value
  2. Multi-Gene panels
    1. By Value
  3. Single-Gene panels
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Research organizations
    1. By Value
  3. Hospitals/Clinics
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction (PCR)
  1. By Value
3. Next-Generation Sequencing (NGS)
  1. By Value
4. Fluorescence in Situ Hybridization
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Tissue biopsy
  1. By Value
3. Liquid biopsy
  1. By Value
By Panel Type
1. Introduction
  1. Panel Type By Value
2. Multi-Gene panels
  1. By Value
3. Single-Gene panels
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research organizations
  1. By Value
3. Hospitals/Clinics
  1. By Value
4. Diagnostic Laboratories
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction (PCR)
    1. By Value
  3. Next-Generation Sequencing (NGS)
    1. By Value
  4. Fluorescence in Situ Hybridization
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Tissue biopsy
    1. By Value
  3. Liquid biopsy
    1. By Value
4. By Panel Type
  1. Introduction
    1. Panel Type By Value
  2. Multi-Gene panels
    1. By Value
  3. Single-Gene panels
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Research organizations
    1. By Value
  3. Hospitals/Clinics
    1. By Value
  4. Diagnostic Laboratories
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Lung Cancer Genomic Testing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

QIAGEN N.V.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
CENTOGENE N.V.
BGI
CeGaT GmbH
Illumina, Inc.
Hoffmann-La Roche Ltd.
Abbott Laboratories
CD Genomics
NeoGenomics Laboratories
Admera Health
OncoDNA
OPKO Health, Inc.
Invitae Corporation
Veracyte, Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment